HIRSCHSPRUNGS-DISEASE - GENETIC MUTATIONS IN MICE AND MEN

Citation
K. Robertson et al., HIRSCHSPRUNGS-DISEASE - GENETIC MUTATIONS IN MICE AND MEN, Gut, 41(4), 1997, pp. 436-441
Citations number
50
Categorie Soggetti
Gastroenterology & Hepatology
Journal title
GutACNP
ISSN journal
00175749
Volume
41
Issue
4
Year of publication
1997
Pages
436 - 441
Database
ISI
SICI code
0017-5749(1997)41:4<436:H-GMIM>2.0.ZU;2-M
Abstract
Hirschsprung's disease is a neuronal dysplasia of the hindgut, charact erised by a loss of neurones, which affects about 1 in 5000 live birth s.(1) Genetic factors have been implicated in the aetiology of this di sease in about 20% of cases and a dominant pattern of inheritance has been revealed in several families.(2 3) The pathogenesis of the agangl ionosis is often attributed to a failure of migration of neural crest cells, although this has not been proven. Recently, mutations in a dev elopmentally regulated receptor tyrosine kinase gene, ret, and mutatio ns in the endothelin receptor-B gene (ENDR-B) have both been linked to familial Hirschsprung's disease in humans.(4-6) Moreover, certain mut ant mouse strains-namely piebald lethal and lethal spotted-exhibit str iking similarities to the human condition. The mutation which gives ri se to piebald lethal has now been found to be in the ENDR-B gene,(7) a nd the mutation associated with lethal spotted occurs in the gene for endothelin-3 (ET-3), a ligand for ENDR-B.(8) Two transgenic mouse line s have been developed which also reflect the human disease: ret-k(-), which has a loss of function mutation of the ret gene,(9) and ENDR-B n ull.(10) In addition, the introduction of a Lac-Z reporter gene into n eural crest cells of aganglionic mice has made it possible to study di rectly the fate of enteric neuroblasts which are affected by ''Hirschs prung's-like'' mutations.(11) Here, we review the possible roles of RE T and endothelin in the normal development of the enteric nervous syst em, and the significance of their mutated forms in the pathogenesis of familial aganglionosis. This review focuses on recent advances in our understanding of the genetic basis of the lesions which have been imp licated in congenital forms of Hirschsprung's disease. Disruption of t hese genes in the mouse, either by transgenic ''knockout'' approaches or in mutant mouse lines, offers the prospect of greater understanding of both the cellular and developmental bases of the human disease.